chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache beginning roughly 8 hours post-injection. Tried to sleep off, woke up 4 hours later with chills. Headache still present, took some Ibuprofen. Headache broke around 2-3 hours later, felt fine after. Got hit with fatigue (likely due to poor sleep) around 1pm the next day. Slept it off, woke up feeling fine. Haven't had any follow-up effects in the nearly one year since. Mainly submitting my experience to better understand VAERS.
Rosacea on face. Treated withTriamcinolone Adetonide Cream USP, .025%. Condition persists to present (about 6 months) but moderating.
On 11/17/21 woke with swollen eyes (about 7am). By evening 0f 11/17 reported to have hives at back and spreading to stomach and extremities and scalp with itchiness.  Parents consulted up with telehealth on 11/17 8P.  Benadryl and prednisone were prescribed.  parents are also following up with Pediatrician.  Hydrocortisone cream is also being used to reduce itchiness.  Parent reported that medicine are being effective in control of these symptoms.
9 month old had red, raised rash behind head, behind neck, on back, behind arms and cried when crawling. Rash got increasingly worse until Benadryl was given 5/17/13 at 9:30am, then symptoms lessened. Indicative of systemic reaction.
Moderna vaccine is only approved for adults 18 years of age and over.  No adverse reaction was noted at time of vaccine.
Fatigued; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigued) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigued). At the time of the report, FATIGUE (Fatigued) outcome was unknown.            No concomitant medications were provided. No treatment details were provided.   Reporter did not allow further contact
(11/17/09) itching, hives pt did not report till next visit 3/4/2010.
Worsening arm pain since flu shot on 09/21/2021. Hardly can use left arm now due to stiffness, inflamation, extreme soreness, and periodic excruciating nerve pain.
10-12-19 PM JOINT AND MUSCLE ACHES: HIPS HURT. ARMS HURT.  BACK HURT.  EVERYTHING  ACHED 10-21-19 CONTACTED RN AT HEALTH DEPARTMENT. POSSIBLE FLU LIKE SYMPTOMS. IF NOT BETTER BY FRIDAY, CONTACT PHYSICIAN. 10-25-19 WENT TO OFF HOURS CLINIC. LPN TOOK LABWORK. 150/90 10-26-19 RESULTS "VIRAL INFLAMMATION".  ENCOURAGED TO GET B/P CUFF AND MONITOR. APPOINTMENT W/DR. JANUARY 2, 2020...FIRST APPOINTMENT AVAILABLE. 11-14-19 CONTACTED HEALTH DEPARTMENT AGAIN.  11-15-19 HD WORKED WITH PATIENT TO COMPLETE VAERS REPORT. 20 MIN HOT SHOWERS  11-15-19 SOME IMPROVEMENT. NO WADDLING.
Shortness of breath; heaviness in chest; headache; dizziness; nausea; The patient also received first dose of unspecified other vaccine on the same day of COVID vaccine; This is a spontaneous report from a contactable nurse (patient) reported  for herself.  A 53-year-old female (not pregnant at the time of vaccination) patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 29Dec2020 11:30 at single dose for COVID-19 immunization at a hospital. The patient also received first dose of unspecified other vaccine on the same day of COVID vaccine (29Dec2020) at left arm. The patient's medical history included diabetes type 2, arthritis, known allergies to Shrimp and penicillin. The patient's concomitant medications received within 2 weeks of vaccination included unspecified medications. No other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took lisinopril and experienced drug hypersensitivity (Known allergies: Lisinopril). The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested for COVID-19 post the vaccination. On 29Dec2020 11:30, the patient experienced shortness of breath, heaviness in chest, headache, dizziness and nausea. Treatment for above events included antihistamine. The outcome of the events shortness of breath, heaviness in chest, headache, dizziness and nausea was recovered in Dec2020. The events were reported as non-serious by the reporter.  Information on the lot/batch number has been requested.
Patient reports that during the night 5/19/2008 he woke with itching and rash. Patient was seen 5/22/2008 with raised urticarial wheals ranging from 2-4cm on trunk and extremities. No local reaction nor wheals at injection site. Patient reports that wheals "come and go" and improves with Benadryl.
Diarrhea, severe joint pain/body aches, chills, and dizziness on 12/30/2020.
Patient slept for about 16 hours a day; Severe fatigue; Vomiting; Nausea; Fever; This is a spontaneous report from a contactable consumer (patient's mother). A 16-year-old female patient (daughter) received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 15May2021, as a single dose for COVID-19 immunization. The patient's medical history included ongoing asthma (gotten better in the past year or so but had it almost her whole life investigation assessment: No) and cold. Concomitant medications were not reported. The patient's mother reported that on 16May2021, the patient (daughter) developed nausea and vomiting for about 12 hours and treated with dramamine and went away, completely resolved. She also had fever of up to 102 Fahrenheit for about 3 days that went away and also presents severe fatigue that lasted from 9 to 10 days that started on 18May2021 and was only improving now and wanted to know if that would that be an allergic reaction, when she presented fatigue the patient slept for about 16 hours a day. The hours that she was awake she was normal, she was nor weak. Caller wants to know what can they expect "fatigue wise" with the second dose and why do patients develop fatigue. She also wants to know if a "severe fatigue" could last several days. A higher incidence was reported with the second dose of the vaccine with adults and adolescents. No information on how long the fatigue would last. The outcome of the events nausea and vomiting was resolved on 16May2021 and fever was resolved on an unknown date. Outcome of the severe fatigue was recovering and for the event patient slept for about 16 hours a day, it was unknown.  Follow-up attempts are needed. Information on Lot/Batch number is requested.
Immunization site was burning shortly after she got the vaccine, when she got home. Immunization site started hurting one to two hours after the vaccine was delivered. It was an aching feeling that went from shoulder down to the elbow starting 9/4. Her arm hurt when she moved it and she was having pain in her neck and back on the left side of her body. She said her arm is feeling much better today 9/6, but still aches at the injection site a little. Per patient, she is recovering/improving.
Moderna Vaccine expired 10/20/2021 at 0600 at refrigerator temperature. Vaccine administered approximately 5.5 hours after expiration time on 10/20/2021. Moderna Manufacturing company consulted and stated: It is recommended that the vaccine be used by 30 days to the expiration date and time; however, it is ok to use by the end of the day on the 30th day. No treatment required.
Chest Pain - Heart Attack like, Dizziness, Nausea, Fainting, and eventually AFIB.   First emergency room visit was via ambulance on May 3, 2021  approximately 3 weeks after firs vaccination.   1st vaccination date was May 14 at 9:30AM.  Was transported by ambulance as heart attach symptoms were severe.  Monitored by EKG and in emergency room cardiac unit for the day.  Ran two blood tests and troponin levels were acceptable so released at approximately 6:00 PM.   Second event was two days after receiving second vaccination.   Vaccination occurred on May 19 at 9:00 AM and was again transported to the hospital with Heart attack symptoms at 10:00 AM on Friday May 21.  Monitored by EKG and in emergency room cardiac unit for the day.  Ran two blood tests and troponin levels were acceptable.  Prescribed a Heart Monitor for 14 days and released at approximately 5:00 PM.   Third occurrence was Monday May 31.  Heart attack symptoms chest pain, accelerated heart rate.   Went into AFIB.   Transported to Hospital.  (Morton Plant).  Verified AFIB reading by heart monitor.  Admitted to the hospital for two days.  EKG monitors, Blood tests.   Released Tuesday at 4:00 PM.  Prescribed Multaq by on call Cardiologist to prevent AFIB.    Met with Cardiologist Monday June 7th.  Diagnosed as Pericarditis or myocarditis.   Prescribed Mutlaq for the AFIB, Indomethacin for anti inflammatory and Low dose aspirin for stroke and blood thinner.   Recover expected to be Long.
CPAP machine- shortness of breath, dizziness, pale and weak, passed out twice, taken to emergency room by ambulance.  Hit head.
Pt received required vaccines; fainted approximately 5 minutes after vaccine administration.  Sx of vasovagal response included; LOC, loss of bladder control; body shaking.  Patient braced in chair to prevent injury; regained consciousness w/o ammonia capsule.  Given juice, ice pack, allowed to lie down with feet elevated for 20-30 minutes.
The patient reported shortness of breast and difficulty breathing.  The patient's husband stated that he witnessed the patient having a seizure.   Patient advised to call EMS.  EMS took the patient to hospital.   The patient was stabilized after receiving emergency treatment.
Redness and swelling (warm, tenderness) noted by mom 2nd day after vaccines were given. Provider prescribed MOTRIN and alternate warm and cold compress every other hour.
Fainted,  Dizziness,  pain at injection site, headache,  chills, body aches,; Fainted,  Dizziness,  pain at injection site, headache,  chills, body aches,; Fainted,  Dizziness,  pain at injection site, headache,  chills, body aches,; Fainted,  Dizziness,  pain at injection site, headache,  chills, body aches,; Fainted,  Dizziness,  pain at injection site, headache,  chills, body aches,; Fainted,  Dizziness,  pain at injection site, headache,  chills, body aches,; DOSE NUMBER 3; DOSE NUMBER 3; This is a spontaneous report from a contactable consumer(patient). A 70-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown) via an unspecified route of administration, in the left arm on 14Aug2021 at 11:15 (at the age of 70-years-old) as dose 3, single for covid-19 immunisation. Facility type vaccine was pharmacy or drug store. Medical history included diabetes, thyroid disease, high blood pressure all from an unknown date and unknown if ongoing. Known allergies reported for narcotics, opioids. Concomitant medications included levothyroxine sodium (SYNTHROID), hydrochlorothiazide, cyanocobalamin (VITAMIN B12), vitamin d3 (VITAMIN D3) all taken for an unspecified indication, start and stop date were not reported. Historical vaccines included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown) via an unspecified route of administration, on an unspecified date, as dose 1, single and dose 2, single both for covid-19 immunisation. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. On 15Aug2021 at 19:30 the patient experienced fainted, dizziness, pain at injection site, headache, chills, body aches, and dose number 3 (extra dose administered and off label use). The patient did not receive any treatment for the event. Outcome of the events was recovering.  Information on lot/ batch number has been requested.
Information has been received from a nursing supervisor concerning a 20 year old female who has an allergy to penicillin and minoglycine who on 27-Dec-2008 at 12:15 was vaccinated with GARDASIL (lot# 695165/1425F). On 27-DEC-2006 at 12:15, the patient reported that "when she was given the shot she felt it go down her arm and her arm felt heavy all day long. "The next day her arm was better. No product quality complaint was involved. Subsequently, the patient reported that her arm felt dead. At the time of this report, the outcome of the event was unknown. Additional information has been requested.
Pt states injection site became sore and red 30 minutes after vaccine administration.  Site was nickle sized and stayed that way for 3 days, it then slowly shrank down to pea size as of 21 Mar 05.  Redness has lasted for 3 weeks at the site of the injection.
Pt recvd 2 doses of Engerix-B & immed following 2nd dose 5JUN92 exp local pain which went away; 7JUN92 devel fatigue, body ache, low grade fever, & pruritus; seen by MD: no meds given; sx persisted as of 10JUN92; also bursitis;
Teachers reported strange actions (trying to eat puzzle, talking incoherently then not talking all, acted as if eevrything in slow motion), took to ER where actions were same, had a large seizure at 3:30-4:00pm, admitted to icu, placed on ventilator, started having small trembling seizures, placed on seizure & sedations meds, seizure cycles were broken around 1:00 am on 11/14/2009. 11/25/09 DC summary and hosp. records received for dates 11/13/09 to 11/16/09. DX: seizure, respiratory failure, epilepsy. Pt presented w/ status epilepticus and respiratory failure, was intubated in ER, seizure resolved w/ med tx. Pt returned to what is patients baseline norm. Upon dc pt stable. Parent states received H1N1 vax this day. Assessment once admitted noted to be febrile, all tests (-).
became sick from a flu vaccine, almost died on two different occasions from flu shots, ended up in hospital; Initial information received on 18-Oct-2023 regarding an unsolicited valid Social Media serious case received via consumer.  This case involves an unknown age female patient who became sick from a flu vaccine, almost died on two different occasions from flu shots, ended up in hospital after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, lot number, form, expiry date: unknown) via unknown route in unknown administration site for prophylactic vaccination (immunization).  On an unknown date the patient developed a serious became sick from a flu vaccine, almost died on two different occasions from flu shots, ended up in hospital (illness) (unknown latency) following the administration of influenza vaccine.   It was unknown if any lab data/test results available.  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event.  Outcome: Unknown for the event  Seriousness criteria: The patient was hospitalized for this event.; Sender's Comments: Sanofi company comment dated 27-OCT-2023: This case involves an unknown age female patient who became sick from a flu vaccine, almost died on two different occasions from flu shots, ended up in hospital after receiving influenza vaccine.The time to onset was compatible with the role of vaccine. The clinical course of the event was not provided. Furthermore, information regarding condition at the time of vaccination, role of medical history, concomitants, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of an individual vaccine cannot be assessed. SanofiPVPortal20231020000606:PORTAL ID
pt recvd vax & ran t 104-105 & cried off & on; pt was lethargic, had 3 sz; was jerking & eyes rolled back; pt taken to ER & dx w/ bilat. O.M.;
since the injection on 5/20 my systolic blood pressure has gone from 125 on 5/21 to 194 on 5/23
Back injury; This case was reported by a consumer via call center representative and described the occurrence of back injury in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced back injury. On an unknown date, the outcome of the back injury was unknown.   It was unknown if the reporter considered the back injury to be related to Shingrix.     Additional Information: GSK Receipt Date: 29-JUL-2022 Reporter's Comments: The reporter was the patient, who received his first dose of shingrix in August 2019.  The patient was stated that after his first dose had sustained a back injury.  The patient did not provide additional details about the back injury.  The patient also stated that had not yet received his second dose of Shingrix. The patient did not provide consent to follow-up.
Received Td 10/23/2002. Next day pt noticed pain, redness, swelling right deltoid area that spread down right arm over next few days. Seen MD on 10/28/2002 to evaluate reaction. Right upper arm was warmer than left with redness and induration over middle  1/3 of upper arm. Had taken Benadyl.
Post vax on 07/19/2001 the patient experienced pain in her left arm. By 07/20/2001 the patient was unable to lift her arm above should level. There is no local redness or swelling. The patient has been seen by a chiropractor 6-7 times since August. The patient is being treated with exercises and heat. The patient feels the arm is worsening.
Vaccine received at 9 am on 10/17/2009 and at about 5 or 6 pm she had stiffness and soreness in the left shoulder to neck.
Confusion, Headache, Myalgia, Arthralgia, Swelling and pain at the injection site, fatigue, tingling, feeling of heat in feet, chest tightness, eye pain.   Narrative:
granuloma annulare; This spontaneous case was reported by a physician and describes the occurrence of GRANULOMA ANNULARE (granuloma annulare) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 000000) for COVID-19 prophylaxis.     No Medical History information was reported.    In March 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Jan-2023, the patient experienced GRANULOMA ANNULARE (granuloma annulare). At the time of the report, GRANULOMA ANNULARE (granuloma annulare) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered GRANULOMA ANNULARE (granuloma annulare) to be related.    Concomitant medication of the patient was not reported.  It was reported by the reporter that the 2nd Moderna booster dose which his wife had received, might be the cause of the granuloma annulare.  No treatment information was provided by the reporter.   Reporter did not allow further contact
Initial information received on 27-Oct-2018 regarding an unsolicited valid non-serious case received from a physician. This case involves patient who received a first dose of an expired vaccine IMOVAX RABIES (lot number not reported M15651M, expiration date 23-Oct-2018) via unknown route in unknown administration site on 24-Oct-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was a case of actual medication error due to expired vaccine used. It was not reported if the patient had any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
first vaccine shot develop Nasal Abscess in three days,  received second and final shot (3/24/21) Also develop Nasal Abscess in three days.  Could have set a clock to it. Had to be treated by Dr. with some antibiotics. Never had any history of having a Nasal Abscess
A legal complaint was received from an attorney regarding an adult male decedent. The decedent history includes exposure to asbestos and asbestos-containing products. According to the legal complaint, "sometime in the 1950's, decedent was administered OPV or IPV." On or about September 2001, at 60 years of age, the decedent was reportedly diagnosed with mesothelioma. The legal complaint states that the "contaminated vaccine products were toxic and carcinogenic" and that the "decedent's exposure to asbestos, asbestos-containing products, and SV40 virus caused severe and permanent injury to the plaintiff, including, but not limited to breathing difficulties, asbestosis, lung and/or other cancer, mesothelioma, and/or other lung damage." On 11/8/01, the decedent died. The autopsy reported cause of death was respiratory failure due to malignant mesothelioma of pleura.
Morning after vaccination had severe diarrhea lasting 1 day then moderate diarrhea for the next 2 days. Had headache and cold symptoms which lasted a total of 9 days.
This case was reported by a physician via sales rep and described the occurrence of injection site swelling in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site swelling and injection site erythema. On an unknown date, the outcome of the injection site swelling and injection site erythema were unknown. It was unknown if the reporter considered the injection site swelling and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. After vaccination with SHINGRIX, the patient experienced a local reaction with redness and swelling. This case has been linked with case US2018GSK169678, reported by same reporter.
vomiting began evening of day inject given, cont next day; pt seen by MD diagnostic procedures begun; diarrhea began day p/inject & cont 2 days; temp never exceeded 100.4;
itching; ripped all the skin off the back from my hand practically because I am itching between my fingers every where on my body; in between my fingers, my shoulders, my joints everything was itching inside and burning; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 64-year-old female patient received bnt162b2 (BNT162B2), administration date 08Oct2021 (Lot number: FF8841) as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (1st dose), administration date: 21Mar2021, for COVID-19 immunization; Bnt162b2 (2nd dose), administration date: 12Apr2021, for COVID-19 immunization.  The following information was reported: PRURITUS (non-serious) with onset Oct2021, outcome "unknown", described as "itching"; SKIN LESION (non-serious) with onset Oct2021, outcome "unknown", described as "ripped all the skin off the back from my hand practically because I am itching between my fingers everywhere on my body"; SKIN BURNING SENSATION (non-serious) with onset Oct2021, outcome "unknown", described as "in between my fingers, my shoulders, my joints everything was itching inside and burning". Therapeutic measures were not taken as a result of pruritus, skin lesion, skin burning sensation.  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible. No further information is expected.